Skip to main content
Log in

Antineoplastics

Acute hypersensitivity reaction in the form of complement activation-related pseudoallergy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ma J, et al. Improved efficacy and safety of low-dose oxaliplatin/pegylated liposomal doxorubicin/S-1 regimen in advanced gastric cancer: a cohort study. Annals of Palliative Medicine 10: 12821-12830, No. 12, Dec 2021. Available from: URL: http://doi.org/10.21037/apm-21-3584

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1934, 42 (2022). https://doi.org/10.1007/s40278-022-28423-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28423-1

Navigation